Merck & Company’s intrauterine device (IUD) NuvaRing has been linked to an increase in blood clots, pulmonary embolisms, strokes, heart attacks and more. The pharmaceutical giant is defending approximately 1,250 NuvaRing injury lawsuits, and injured victims will soon get their day in court, as trials are set to begin in October 2013.
The Dangers of Third- and Fourth-Generation Progestins
Third- and fourth-generation birth control products contain progestins that were not in earlier generations of birth control. Women were told that these new forms of contraceptives were better, easier to use and had less risk. Unfortunately, tens of thousands of women have suffered serious side effects with the use of products such as NuvaRing, Yaz, Yasmin, Ocella and others.
Unlike pill forms of birth control, NuvaRing is a flexible plastic ring that a woman inserts into her vagina. It releases a low dose of a progestin (called etonogestrel) and estrogen over a period of three weeks to suppress ovulation and prevent pregnancy. However, despite the manufacturer’s claims that NuvaRing is safe, thousands of women have suffered serious NuvaRing side effects, including deep vein thrombosis (DVT), blood clots, pulmonary embolisms, strokes, heart attacks and more. According to Yahoo News, Merck now faces 1,250 NuvaRing injury lawsuits, with the first trial likely to begin in October.
Have You Been Injured?
If you’ve been injured by a third- or fourth-generation contraceptive such as NuvaRing, Yaz, Yasmin, Ocella or Beyaz, contact The Driscoll Firm, LLC, to discuss your situation and determine whether you might be entitled to compensation for lost income, pain and suffering, emotional distress, medical bills, medical monitoring and more. We offer free initial consultations so that you can get the facts and make an informed decision about whether taking legal action makes sense for you.